viral
respiratori
infect
particularli
rhinoviru
infect
common
caus
asthma
exacerb
correspond
author
tel
fax
email
address
mnijhui
umcutrechtnl
nijhui
johnston
et
al
report
viral
infect
associ
asthma
exacerb
children
johnston
et
al
picornavirus
human
rhinovirus
hrv
enterovirus
account
virusinduc
asthma
exacerb
also
adult
asthma
patient
respiratori
viru
infect
associ
major
exacerb
nicholson
et
al
corn
et
al
observ
hrv
infect
usual
lead
sever
symptom
longer
durat
lower
respiratori
tract
lrt
diseas
asthmat
otherwis
healthi
individu
corn
et
al
howev
exact
mechan
hrv
caus
exacerb
asthma
unclear
one
postul
mechan
hrvspecif
intracellular
adhes
molecul
receptor
upregul
asthma
patient
therefor
increas
suscept
hrv
infect
manolitsa
et
al
yamaya
et
al
anoth
mechan
suggest
increas
suscept
hrv
infect
bronchial
epitheli
cell
asthmat
patient
wark
et
al
author
suggest
indic
abnorm
innat
immun
respons
cell
infect
hrv
result
increas
viral
rna
express
viru
releas
cell
asthmat
cell
healthi
control
role
postinfecti
immun
respons
suggest
studi
patient
allerg
rhiniti
asthma
high
ratio
helper
respons
tend
less
sever
symptom
hrv
challeng
shed
less
viru
sputum
compar
low
ratio
respons
magnitud
cytokin
respons
either
sputum
upper
respiratori
tract
nasal
secret
correl
increas
airway
hyperrespons
grunberg
et
al
data
suggest
differ
immun
respons
may
associ
differ
viral
replic
sever
ill
base
observ
investig
relationship
sever
lrt
symptom
observ
asthmat
patient
healthi
volunt
cytokin
respons
viral
replic
upper
respiratori
tract
urt
prospect
studi
septemb
august
approv
local
ethic
committe
recruit
peopl
asthma
age
year
gener
practic
asthmat
diagnos
accord
dutch
asthma
guidelin
show
revers
peak
expiratori
flow
pef
andor
forc
expiratori
flow
administr
geijer
et
al
patient
treat
usual
variou
combin
inhal
therapi
corticosteroid
parasympathicolyt
asthmat
subject
histori
atopi
also
enrol
healthi
control
subject
control
match
asthmat
subject
histori
asthma
allerg
rhiniti
eczema
atopi
famili
member
written
inform
consent
obtain
particip
one
season
asthmat
control
subject
daili
record
urt
lrt
sign
symptom
rate
mild
sever
urt
symptom
score
defin
runni
stuffi
itchi
nose
sneez
waterysor
eye
sore
throat
hoars
voic
headach
lrt
symptom
score
includ
cough
wheez
difficult
breath
short
breath
effort
johnston
et
al
patient
asthma
group
record
peak
flow
morn
afternoon
peak
flow
score
use
peak
flow
instrument
mini
wright
meter
clement
clark
intern
london
uk
three
time
success
record
highest
valu
median
baselin
score
subject
mean
peak
flow
score
five
consecut
time
point
around
baselin
week
subject
ask
contact
investig
urt
symptom
score
total
andor
lrt
symptom
score
exceed
result
home
visit
within
h
followup
visit
perform
day
day
week
week
baselin
durat
urt
lrt
symptom
determin
number
day
urt
lrt
symptom
score
individu
baselin
score
respect
sever
urt
lrt
symptom
defin
maximum
urt
lrt
symptom
score
respect
visit
nasal
wash
nw
collect
nostril
describ
previous
grunberg
et
al
briefli
ml
steril
salin
instil
nostril
collect
tube
tube
mix
thoroughli
immedi
place
wet
ice
one
millilit
nw
use
viru
cultur
remaind
mix
equal
volum
dilut
sputolysin
reagent
mm
dithiothreitol
mm
phosphat
buffer
calbiochemnovabiochem
corpor
san
diego
ca
aliquot
clarifi
centrifug
g
min
room
temperatur
remain
supernat
fluid
store
c
analysi
convent
viral
cultur
perform
describ
van
elden
et
al
basic
inocul
rhela
tertiari
monkey
kidney
tmk
cell
nation
institut
public
health
environ
rivm
bilthoven
netherland
ml
nw
detect
respiratori
virus
parainfluenza
virus
respiratori
syncyti
viru
rsv
b
influenza
virus
adenoviru
picornavirus
cultur
examin
twice
weekli
day
develop
cytopath
effect
cpe
cpeposit
cultur
viru
identifi
immunofluoresc
monoclon
antibodi
dako
imagen
influenza
virus
b
rsv
b
adenoviru
parainfluenza
virus
hrv
distinguish
enterovirus
acidl
test
shell
vial
cultur
immunofluoresc
test
perform
day
cultur
usual
cytopath
effect
notic
use
mention
monoclon
antibodi
van
elden
et
al
realtim
quantit
rtpcr
perform
store
supernat
fluid
nasal
wash
parainfluenza
viru
picornavirus
van
de
pol
et
al
rhinoviru
specif
realtim
pcr
detect
hrv
subtyp
test
realtim
pcr
influenza
viru
b
rsv
b
human
coronavirus
perform
describ
previous
van
elden
et
al
van
elden
et
al
van
elden
et
al
nijhui
et
al
number
viral
rna
copi
influenza
b
rsv
b
rhinoviru
clinic
sampl
determin
extrapol
standard
curv
gener
amplif
serial
dilut
electron
microscop
em
count
viru
stock
estim
quantiti
human
coronavirus
emcount
viru
stock
avail
viral
copi
express
rel
unit
ru
everi
amplif
cycl
repres
increas
number
viral
rna
copi
viral
load
express
increas
per
cycl
rel
baselin
valu
copi
threshold
cycl
ru
cycl
clb
amsterdam
netherland
biosourc
intern
ca
usa
measur
use
commerci
avail
human
cytokin
elisa
kit
accord
manufactur
recommend
protocol
nw
supernat
assay
duplic
result
express
pgml
limit
sensit
assay
follow
pgml
pgml
pgml
pgml
analys
base
first
episod
infect
subject
differ
asthmat
control
group
analyz
mannwhitney
utest
spss
window
comparison
measur
infect
ill
viral
load
symptom
assess
peak
flow
measur
cytokin
level
asthmat
control
done
wilcoxon
sign
rank
test
spss
window
correl
determin
use
spearman
rank
correl
coeffici
spss
window
area
curv
auc
analysi
includ
viru
load
durat
shed
perform
use
trapezium
rule
matthew
et
al
auc
calcul
data
point
individu
compar
mean
mannwhitney
test
spss
window
total
asthmat
control
subject
enrol
fortythre
report
episod
respiratori
tract
ill
respiratori
viru
detect
pcr
episod
viral
cultur
gave
ad
diagnost
valu
first
episod
respiratori
viru
infect
analysi
asthmat
control
patient
characterist
shown
tabl
signific
differ
seen
number
respiratori
tract
ill
caus
respiratori
viru
asthmat
control
tabl
major
infect
n
caus
hrv
durat
sever
urt
symptom
similar
asthmat
control
group
howev
sever
lrt
symptom
greater
asthmat
compar
control
p
tabl
durat
symptom
lrt
also
significantli
longer
asthmat
patient
p
subgroup
analys
perform
asthmat
popul
indic
signific
clinic
differ
hrv
respiratori
viru
infect
howev
sampl
size
small
use
quantit
realtim
pcr
detect
respiratori
virus
find
signific
differ
studi
group
either
maximum
level
viru
produc
durat
detect
viral
rna
tabl
addit
subject
neither
peak
viru
load
durat
viral
shed
correl
durat
sever
lrt
symptom
lack
correl
observ
subgroup
analysi
limit
hrv
infect
area
curv
plot
viru
load
durat
shed
statist
differ
studi
group
p
dynam
viru
infect
asthma
patient
compar
peak
flow
reduct
lrt
symptom
seem
clear
actual
viral
infect
upper
respiratori
tract
preced
peak
flow
reduct
lrt
symptom
fig
nw
level
proinflammatori
cytokin
significantli
increas
day
compar
baselin
tabl
level
parallel
lrt
symptom
peak
flow
reduct
peak
time
viru
load
declin
fig
signific
differ
respons
could
determin
studi
group
sign
symptom
rti
result
obtain
subgroup
analysi
hrv
perform
detect
nw
asthmat
control
sever
lrt
symptom
asthmat
natur
occur
rti
greater
control
confirm
similar
studi
patient
infect
hrv
corn
et
al
howev
differ
correl
differ
viral
load
durat
viral
shed
urt
proinflammatori
cytokin
urt
recent
studi
virusrel
exacerb
asthma
mainli
focus
hrv
infect
sinc
hrv
frequent
detect
pathogen
set
gern
buss
johnston
et
al
nicholson
et
al
sever
lrt
symptom
asthmat
patient
infect
hrv
attribut
domin
asthma
patient
enhanc
respons
papadopoulo
et
al
gern
et
al
konno
et
al
experiment
hrv
infect
suggest
pattern
cytokin
product
asthmat
patient
may
respons
exacerb
relat
hrv
infect
parri
et
al
gern
et
al
unabl
detect
nw
subject
may
relat
presenc
dtt
sampl
block
detect
line
anoth
observ
cytokin
could
detect
sputum
acut
respiratori
viru
infect
pizzichini
et
al
gern
et
al
potent
chemoattract
activ
neutrophil
also
implic
virusrel
exacerb
asthma
grunberg
et
al
noah
et
al
johnston
teran
et
al
although
see
statist
signific
increas
baselin
observ
differ
intranas
level
asthmat
group
control
group
limit
studi
popul
infrequ
sampl
varieti
differ
virus
hamper
interpret
result
studi
subgroup
analysi
hrv
infect
possibl
number
event
observ
furthermor
sampl
urt
may
reflect
viral
shed
cytokin
express
lrt
percentag
virus
detect
symptomat
asthmat
approxim
similar
previou
studi
use
molecular
diagnost
hrv
detect
nicholson
et
al
van
elden
et
al
studi
determin
mechan
virus
caus
lower
airway
diseas
hamper
difficulti
sampl
lower
airway
shown
hrv
infect
lrt
papadopoulo
et
al
viru
present
urt
may
also
invad
lrt
epithelium
later
stage
infect
therebi
directli
caus
inflamm
bronchospasm
airway
obstruct
wheez
also
possibl
viru
larg
confin
upper
airway
remot
indirect
mechan
provok
asthma
exacerb
conclus
use
quantit
realtim
pcr
show
persist
viru
well
viral
load
upper
respiratori
tract
might
associ
induct
andor
persist
lower
airway
asthmat
symptom
elucid
local
system
inflammatori
respons
virusinduc
asthma
exacerb
remain
challeng
especi
develop
sophist
antiinflammatori
strategi
